first-line targeted therapies for ros1 fusion-positive lung cancers
Published 4 months ago • 10 plays • Length 6:00Download video MP4
Download video MP3
Similar videos
-
1:27
targeted therapies show activity in ros1 fusion-positive lung cancer
-
6:00
later-line targeted therapies for ros1 fusion-positive lung cancers
-
5:53
targeted therapy in non-small cell lung cancer
-
30:32
2023 best of lung: targeted therapies in lung cancer
-
3:06
grace targeted therapies lung cancer 2021 - tki plus chemotherapy as a firstline treatment in ros1?
-
1:49
what targeted therapies are used for people with the ros1 mutation?
-
13:55
ros - dr venkata pradeep babu selection of 1st line therapy for ros 1 rearrangement in nsclc
-
1:05
what targeted therapies are used for people with the alk mutation?
-
28:43
macrocyclic tkis in treatment-naïve and pretreated fusion-positive nsclc and other tumors
-
1:51
dr. riess on ros1 fusions in lung cancer
-
0:44
alk-tkis: targeted therapies for alk-positive nsclc
-
1:06
dr. goldman on targeted therapy options for egfr-, alk-, and ros1-mutated nsclc
-
7:07
ros1 treatment options: crizotinib and entrectinib - 2022 program: targeted therapies forum
-
0:40
evaluating next steps for entrectinib in ros1-positive nsclc
-
40:53
alk and ros1 in lung cancer next generation targeted therapies
-
2:48
targeted therapy resistance mechanisms in alk nsclc
-
0:56
crizotinib for first line treatment of alk or ros1 rearrangements
-
23:52
s1 episode 2: biomarkers and targeted therapies for lung cancer
-
4:05
the evolution of alk/ros1-targeted therapy in nsclc